7月 2026
- 首頁
- Vall d'Hebron Institute of Oncology
7月 2026Vall d'Hebron Institute ...的市場佔有率分析
VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.
Vall d'Hebron Institute of Oncology(包含公司地區)
查看更多網站流量與參與度資訊- vhio.net
Vall d'Hebron Institute of Oncology的熱門網域總造訪量
了解Vall d'Hebron Institute of Oncology市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Vall d'Hebron Institute of Oncology的熱門網域平均造訪時長
分析Vall d'Hebron Institute of Oncology參與度指標。
過去 3 個月平均造訪時長
子公司細目
Vall d'Hebron Institute of Oncology的熱門網域平均頁面瀏覽量
了解Vall d'Hebron Institute of Oncology如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Vall d'Hebron Institute of Oncology
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Vall d’Hebron Institute of Oncology is developing diagnostic test capable of detecting breast cancer from a breast milk sample on Jul 8th '26.In the field of breast cancer, researchers Ana Vivancos, Director of the Cancer Genomics Laboratory at the Vall d'Hebron Institute of Oncology (VHIO), and Cristina Saura, Head of the Breast Cancer Unit in the Department of Medical Oncology at Vall d'Hebron University Hospital, will develop a diagnostic test capable of detecting breast cancer from a breast milk sample.
7月 8, 2026閱讀更多
新聞Vall d’Hebron Institute of Oncology recognized as Severo Ochoa Centre of Excellence on Jun 25th '26.The Vall d'Hebron Institute of Oncology (VHIO) has renewed its accreditation as a Severo Ochoa Centre of Excellence, the highest distinction awarded by Spain's Ministry of Science, Innovation and Universities to scientific research centres.
6月 25, 2026閱讀更多
新聞Francisco Martínez-Jiménez at Vall d’Hebron Institute of Oncology received award Francisco Cobos Young Biomedical Researcher Award at Francisco Cobos Foundation Awards on Jun 22nd '26.Dr Francisco Martínez-Jiménez, Head of the Computational Immunogenomics Group at the Vall d'Hebron Institute of Oncology (VHIO), has been awarded the inaugural Francisco Cobos Young Biomedical Researcher Award, a new distinction established by the Francisco Cobos Foundation to recognise scientific excellence among early-career researchers in biomedicine.
6月 22, 2026閱讀更多
查看所有Vall d'Hebron Institute of Oncology信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
